JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB64159

Anti-MyoD1 antibody

3

(3 Reviews)

|

(35 Publications)

Rabbit Polyclonal MYOD1 antibody. Suitable for WB, sELISA and reacts with Mouse, Human samples. Cited in 35 publications.

View Alternative Names

BHLHC1, MYF3, MYOD, MYOD1, Myoblast determination protein 1, Class C basic helix-loop-helix protein 1, Myogenic factor 3, bHLHc1, Myf-3

3 Images
Western blot - Anti-MyoD1 antibody (AB64159)
  • WB

Ap

Western blot - Anti-MyoD1 antibody (AB64159)

This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab64159 overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP, and visualised using ECL development solution ab133406.

ab64159 detects a band at 45 kDa, while this differs to its predicted molecular weight of 34kDa, the banding pattern observed is consistent with what has been described in the literature PMID : 19352326.

All lanes:

Western blot - Anti-MyoD1 antibody (ab64159) at 1 µg/mL

Lane 1:

Skeletal Muscle (Mouse) Tissue Lysate at 20 µg

Lane 2:

Rh30 Whole Cell Lysate at 5 µg

Secondary

All lanes:

Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/50000 dilution

Predicted band size: 34 kDa

Observed band size: 45 kDa,47 kDa

true

Exposure time: 1min

Sandwich ELISA - Anti-MyoD1 antibody (AB64159)
  • sELISA

Unknown

Sandwich ELISA - Anti-MyoD1 antibody (AB64159)

Standard Curve for Myo-D; dilution range 1 pg/ml to 1 ug/ml using Capture Antibody Mouse monoclonal [5.2F] to MyoD1 (ab16148) at 5ug/ml and Detector Antibody Rabbit polyclonal to MyoD1 (ab64159) at 0.1ug/ml.

Western blot - Anti-MyoD1 antibody (AB64159)
  • WB

CiteAb

Western blot - Anti-MyoD1 antibody (AB64159)

Western Blotting using Anti-MyoD1 antibody, ab64159. Publication image from Zhang, H. et al., 2020, Cell Res, 32839552. Legend direct from paper.

Necroptosis-deficient mice exhibit muscle regeneration defects.a Representative of H&E staining of TA muscle cross-sections from both uninjured (Day 0) and injured (7 and 15 days after CTX injection) WT and Mlkl−/− mice. Scale bars, 50 µm. b Quantification of myofiber sizes from cross-sectional areas (CSAs) of injured mice (7 days after CTX injection) and myofibers with multiple central nuclei out of total cells with central nuclei (in vivo fusion index) 15 days post CTX injection. 3 different views were counted for each mouse. The data are expressed as the means ± SD. n = 6 each for WT and Mlkl−/− mice. c Immunofluorescence staining of MYH3 (green) and Laminin (red) in TA muscle cross sections from both uninjured (Day 0) and injured (4 days after CTX injection) mice. Nuclei were identified by staining with DAPI. Scale bars, 25 µm. d Quantification of the MYH3+ myofiber sizes from CSAs of injured mice (4 days after CTX injection, as representatively shown in c). The sizes of 200 adjacent MYH3+ myofibers were measured for each mouse. Each dot represents an individual myofiber. The data are expressed as the means ± SD. n = 6 each for WT and Mlkl−/− mice. e Immunoblotting analysis of MyoD, MyoG, and MYH3 expression in uninjured (Day 0) or injured (4 days after CTX injection) TA muscles using antibodies as indicated. Whole TA muscle lysates were exacted, as described in Materials and Methods, from 3 mice and pooled together for each condition. HSP70 serves as the loading control. The asterisk (*) denotes the non-specific band. Experiments were repeated independently for three times. f Quantification of the MuSCs in injured TA muscles (3 days after CTX injection) by FACS analysis. MuSCs were isolated as described in Materials and Methods. The histogram represents the percentage of MuSCs (PI−CD11b−CD31−CD45−Sca1−Vcam+ population) out of the total digested mono-nucleus cells. Each dot represents an individual mouse. The data are expressed as the means ± SD. n = 6 each for WT and Mlkl−/− mice. g Immunofluorescence staining of Ki67 (green) and Pax7 (red) in freshly isolated MuSCs (3 days after CTX injection). MuSCs were isolated by FACS and fixed on PDL/Collagen-I pre-coated coverslip, as described in Materials and Methods, followed by immunofluorescence staining using the antibodies as indicated. Nuclei were identified by staining with DAPI. Scale bars, 5 µm. h Quantification of the Ki67+/Pax7+ cells as shown in g. MuSCs isolated from 3 mice were pooled together for immunofluorescence staining in each group. The histogram represents the percentage of Ki67+/Pax7+ cells out of 200 Pax7+cells per genotype. The data are expressed as the means ± SD of 6 images. i qRT-PCR analysis of Ccnd1 mRNA level in MuSCs isolated from injured mice (3 days after CTX injection). The mRNA level of Gapdh was used as the internal control. MuSCs isolated from 3 mice were pooled together for qRT-PCR analysis. The data are expressed as the means ± SD of 3 technical repeats. P values for b, d, and f were determined by unpaired two-tailed t-test; P values for h and i were determined by unpaired two-tailed t-test with Welch’s correction. **P < 0.01; ***P < 0.005. CTX, cardiotoxin; TA, tibialis anterior.

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Human

Applications

WB, sELISA

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "sELISA" : {"fullname" : "Sandwich ELISA", "shortname":"sELISA"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "sELISA-species-checked": "guaranteed", "sELISA-species-dilution-info": "", "sELISA-species-notes": "" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1 µg/mL", "WB-species-notes": "<p></p>", "sELISA-species-checked": "testedAndGuaranteed", "sELISA-species-dilution-info": "0.1 µg/mL", "sELISA-species-notes": "<p>For sandwich ELISA, use this antibody as Detection at 0.5 μg/ml with Mouse monoclonal [5.2F] to MyoD1 (<a href='/en-us/products/primary-antibodies/myod1-antibody-52f-ab16148'>ab16148</a>) as Capture.</p>" }, "Pig": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "sELISA-species-checked": "predicted", "sELISA-species-dilution-info": "", "sELISA-species-notes": "" }, "Rhesus monkey": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "sELISA-species-checked": "predicted", "sELISA-species-dilution-info": "", "sELISA-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

MyoD1 also known as Myogenic Differentiation 1 is a master regulator of muscle differentiation. It functions mechanically as a transcription factor binding to DNA at specific sequences thereby activating the transcription of genes necessary for muscle tissue development. MyoD1 has a molecular weight of approximately 45 kDa. It is expressed in skeletal muscle tissues and also detected in some non-muscle tissues though at lower levels. MyoD1 is essential in the early stages of muscle cell lineage commitment.
Biological function summary

MyoD1 plays an important role in muscle differentiation by activating muscle-specific genes. It belongs to the myogenic regulatory factor family and often operates within a protein complex alongside Myf5 and myogenin aiding in the conversion of mesodermal stem cells into muscle cells. These partnerships enhance its ability to initiate the muscle-specific gene expression that drives myogenesis. MyoD1 acts like a molecular switch shifting cells into the pathway leading to muscle formation.

Pathways

MyoD1 is an integral component of myogenesis and muscle regeneration pathways. MyoD1 interacts with key pathway components such as Myf5 and MRF4 which reinforce MyoD1 activity in muscle tissue lineage determination and cell cycle arrest during differentiation. The activity of MyoD1 in these pathways highlights its role in skeletal muscle growth. MyoD1 also demonstrates functional redundancy with Myogenin as both share overlapping roles in these critical pathways.

MyoD1 is associated with muscular dystrophy and some sarcomas. Aberrant expression or mutations in MyoD1 can disrupt normal muscle differentiation contributing to muscle-related disorders like rhabdomyosarcoma a form of cancer comprising cells resembling skeletal muscle. Its relationship with other proteins like Myf5 further highlights its role in such pathological conditions as faults in these connections can amplify or alter disease progression.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Acts as a transcriptional activator that promotes transcription of muscle-specific target genes and plays a role in muscle differentiation. Together with MYF5 and MYOG, co-occupies muscle-specific gene promoter core region during myogenesis. Induces fibroblasts to differentiate into myoblasts. Interacts with and is inhibited by the twist protein. This interaction probably involves the basic domains of both proteins (By similarity).
See full target information MYOD1

Publications (35)

Recent publications for all applications. Explore the full list and refine your search

eLife 13: PubMed40960171

2025

A novel mouse model for -related muscular dystrophy with analysis of molecular pathogenesis and clinical phenotype.

Applications

Unspecified application

Species

Unspecified reactive species

Dandan Tan,Yidan Liu,Huaxia Luo,Qiang Shen,Xingbo Long,Luzheng Xu,Jieyu Liu,Nanbert A Zhong,Hong Zhang,Hui Xiong

Journal of cachexia, sarcopenia and muscle 16:e13708 PubMed39887939

2025

Defective Cystic Fibrosis Transmembrane Conductance Regulator Accelerates Skeletal Muscle Aging by Impairing Autophagy/Myogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Ziyi Chen,Jiankun Xu,Peijie Hu,Wanting Du,Junjiang Chen,Xiaotian Zhang,Wei Zhou,Jiayang Gao,Yuantao Zhang,Bingyang Dai,Guangshuai Nie,Jun Hu,Liangbin Zhou,Shunxiang Xu,Hisao Chang Chan,Wing-Hoi Cheung,Ye Chun Ruan,Ling Qin

Arteriosclerosis, thrombosis, and vascular biology 43:2023-2029 PubMed37675635

2023

Transcriptomic Profiling Identifies Ferroptosis-Related Gene Signatures in Ischemic Muscle Satellite Cells Affected by Peripheral Artery Disease-Brief Report.

Applications

Unspecified application

Species

Unspecified reactive species

Lillian Tran,Bowen Xie,Edwyn Assaf,Ricardo Ferrari,Iraklis I Pipinos,George P Casale,Roberto Ivan Mota Alvidrez,Simon Watkins,Ulka Sachdev

The Journal of physiology 601:961-978 PubMed36715084

2023

Lipin1 plays complementary roles in myofibre stability and regeneration in dystrophic muscles.

Applications

Unspecified application

Species

Unspecified reactive species

Abdulrahman Jama,Abdullah A Alshudukhi,Steve Burke,Lixin Dong,John Karanja Kamau,Andrew Alvin Voss,Hongmei Ren

The Journal of biological chemistry 299:102978 PubMed36739949

2023

Cardiolipin metabolism regulates expression of muscle transcription factor MyoD1 and muscle development.

Applications

Unspecified application

Species

Unspecified reactive species

Linh Vo,Michael W Schmidtke,Nevton T Da Rosa-Junior,Mindong Ren,Michael Schlame,Miriam L Greenberg

Nature communications 13:6907 PubMed36376321

2022

Replication collisions induced by de-repressed S-phase transcription are connected with malignant transformation of adult stem cells.

Applications

Unspecified application

Species

Unspecified reactive species

Ting Zhang,Carsten Künne,Dong Ding,Stefan Günther,Xinyue Guo,Yonggang Zhou,Xuejun Yuan,Thomas Braun

Biomolecules 12: PubMed36139126

2022

NMR-Based Metabolomic Analysis for the Effects of Trimethylamine N-Oxide Treatment on C2C12 Myoblasts under Oxidative Stress.

Applications

Unspecified application

Species

Unspecified reactive species

Hong Zou,Caihua Huang,Lin Zhou,Ruohan Lu,Yimin Zhang,Donghai Lin

Neurourology and urodynamics 41:1539-1552 PubMed35842827

2022

The role of spinal cord tractography in detecting lesions following selective bladder afferent and efferent fibers injury: A novel method for induction of neurogenic lower urinary tract dysfunction in rabbit.

Applications

Unspecified application

Species

Unspecified reactive species

Shaghayegh Sadeghmousavi,Alireza Soltani Khaboushan,Fahimeh Jafarnezhad-Ansariha,Reza Nejad-Gashti,Maryam Farsi,Reza Esmaeil-Pour,Maryam Alijani,Masoumeh Majidi Zolbin,Hassan Niknejad,Abdol-Mohammad Kajbafzadeh

Biochemical and biophysical research communications 609:163-168 PubMed35436627

2022

Attenuated cell-cycle division protein 2 and elevated mitotic roles of polo-like kinase 1 characterize deficient myoblast fusion in peripheral arterial disease.

Applications

Unspecified application

Species

Unspecified reactive species

Ricardo Ferrari,Guangzhi Cong,Ansuman Chattopadhyay,B Xie,E Assaf,K Morder,Michael J Calderon,Simon C Watkins,Ulka Sachdev

Cells 11: PubMed35406727

2022

Inflammatory Caspase Activity Mediates HMGB1 Release and Differentiation in Myoblasts Affected by Peripheral Arterial Disease.

Applications

Unspecified application

Species

Unspecified reactive species

Ricardo Ferrari,Bowen Xie,Edwyn Assaf,Kristin Morder,Melanie Scott,Hong Liao,Michael J Calderon,Mark Ross,Patricia Loughran,Simon C Watkins,Iraklis Pipinos,George Casale,Edith Tzeng,Ryan McEnaney,Ulka Sachdev
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com